Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.

Front Pharmacol · 2013 · PMC3627987 · PMID 23616769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Epigallocatechin-3-gallate alone showed a trend toward reduction of IL-8, CCL2, IL-1β, and TGFβ release from non-treated cell.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.